TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ENTA

Enanta Pharmaceuticals Inc

Healthcare · Biotechnology

12.50$ -1.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Enanta Pharmaceuticals Inc (ENTA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.3% of the shares are freely tradable; institutional investors hold 92.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 92.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 4.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 77.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 29Mio.

Largest Shareholders

Institutions

Institutions ENTA
Name Stake (%) Shares Change (%) Date
HHG PLC 12.99 3,784,055 +1.5 03/31/2026
BlackRock Inc 10.66 3,103,768 +0.9 03/31/2026
Farallon Capital Management, L.L.C. 9.86 2,871,862 +3.6 03/31/2026
Krensavage Asset Management, LLC 9.84 2,866,138 +0.0 06/30/2026
Deep Track Capital, LP 4.96 1,444,167 -26.2 06/30/2026
Vanguard Capital Management, LLC 4.04 1,178,049 +0.0 03/31/2026
Spruce Street Capital LP 3.74 1,088,731 +16.7 06/30/2026
Vanguard Portfolio Management, LLC 3.26 948,904 +0.0 03/31/2026
Acadian Asset Management LLC 3.02 880,023 +7,563.7 03/31/2026

Funds

Funds ENTA
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.01 877,120 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings ENTA
Person Role Shares Value As of Type
Rottinghaus Scott T. Chief Medical Officer 23,787 297,338 $ Aug 8, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 8, 2026 Rottinghaus Scott T. Chief Medical Officer Other 1,467 13.34 19,570

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?